Chickenpox: managing the symptoms
Posted 16 Jan, 2023 | Source: https://www.happiesthealth.com/
Treating symptoms such as high-grade fever, itchy rashes and body pain is key for those infected with chickenpox
What you need to know about nasal vaccines
Posted 04 Jan, 2023 | Source: https://thedailyguardian.com/
As the world once again braces itself for the new wave of Covid-19 virus, nasal vaccines have now offered a sniffing hope to the people.
Of third Covid variant BF.7, third booster dose and precautions
Posted 28 Dec, 2022 | Source: https://www.thehansindia.com/
Due to the rising number of cases in the USA, China, and Europe, Covid-19 and it's new variants have caused a lot of havoc amongst the public.
The party is over at 1 am
Posted 28 Dec, 2022 | Source: https://bangaloremirror.indiatimes.com/
Masks should be worn at all times; pregnant women, children may have to skip the party?
Spike outside; 0 cases in Bengaluru
Posted 23 Dec, 2022 | Source: https://bangaloremirror.indiatimes.com/
Though there are no covid patients in city’s hospitals as of now, docs advise caution
Foxed by monkeypox?
Posted 21 Aug, 2022 | Source: https://www.deccanherald.com/
While the smallpox vaccine may not protect you from monkeypox forever, the viral illness is self-limiting and gets cured in around three weeks, writes Dr Swati Rajagopal
Right time to get your booster dose? It’s now
Posted 08 Jul, 2022 | Source: bangaloremirror.indiatimes.com
City docs welcome reduction in gap between second dose and booster shot to help increase vax coverage among people in wake of rising covid cases
Two Delta-Omicron co-infection cases found in Bowring, patients discharged
Posted 22 Feb, 2022 | Source: deccanherald.com
The state surveillance unit has been asked to check the genomic sequencing reports of two-third patients who died in January
Covid boosters for 18-60 age group mooted
Posted 19 Jan, 2022 | Source: ewstrailindia.com
Bengaluru: While the State is seeing a rise in the Covid- 19 hospitalisations, mainly among the unvaccinated, the health experts are debating whether it is time to administer a third dose for those in the age group of 18-60 years.
